Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,592 | -32,463 | -15,520 | -73,447 | -56,157 |
| Depreciation Amortization | 4,372 | 2,897 | 1,430 | 5,429 | 3,994 |
| Income taxes - deferred | -47 | -44 | -37 | -3,075 | -2,254 |
| Accounts receivable | N/A | N/A | N/A | 5,800 | N/A |
| Accounts payable and accrued liabilities | 1,358 | 967 | -524 | -3,378 | 417 |
| Other Working Capital | -12,551 | 2,741 | 1,285 | 6,171 | 17,053 |
| Other Operating Activity | 5,434 | 2,074 | 1,544 | 11,575 | 5,625 |
| Operating Cash Flow | $-42,026 | $-23,828 | $-11,822 | $-50,925 | $-31,322 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -614 | -500 | -308 | -5,413 | -5,566 |
| Investing Cash Flow | $-614 | $-500 | $-308 | $-5,413 | $-5,566 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,326 | 861 | 503 | 2,035 | 1,926 |
| Other Financing Activity | 0 | 0 | 0 | -163 | -163 |
| Financing Cash Flow | $1,326 | $861 | $503 | $1,872 | $1,763 |
| Exchange Rate Effect | 5,326 | -849 | -492 | 2,171 | 1,049 |
| Beginning Cash Position | 142,090 | 142,090 | 142,090 | 194,385 | 194,385 |
| End Cash Position | 106,102 | 117,774 | 129,971 | 142,090 | 160,309 |
| Net Cash Flow | $-35,988 | $-24,316 | $-12,119 | $-52,295 | $-34,076 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,026 | -23,828 | -11,822 | -50,925 | -31,322 |
| Capital Expenditure | -614 | -500 | -308 | -5,413 | -5,566 |
| Free Cash Flow | -42,640 | -24,328 | -12,130 | -56,338 | -36,888 |